An Automated 2D-Capillary Electrophoresis System

Information

  • Research Project
  • 6480211
  • ApplicationId
    6480211
  • Core Project Number
    R43CA096059
  • Full Project Number
    1R43CA096059-01
  • Serial Number
    96059
  • FOA Number
    PAR-01-105
  • Sub Project Id
  • Project Start Date
    9/30/2002 - 22 years ago
  • Project End Date
    8/31/2004 - 20 years ago
  • Program Officer Name
    FELSENFELD, ADAM
  • Budget Start Date
    9/30/2002 - 22 years ago
  • Budget End Date
    8/31/2004 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/27/2002 - 22 years ago
Organizations

An Automated 2D-Capillary Electrophoresis System

DESCRIPTION (provided by applicant): For complex protein mixtures, including cell lysates, containing thousands of proteins, 2-D gel electrophoresis separation (2D-PAGE) is the standard method used to separate and isolate individual proteins for analysis. In addition to being useful for identifying individual proteins, it is also used to monitor changes in the amount of a specific protein or proteins as an indication of the onset of cancer in tissue or how cancer growth is affected by environmental influences or by treatment methods. We will develop a capillary equivalent to the standard 2D-PAGE method. It will offer several advantages compared to 2 D-PAGE, including automation, quantitative measurement in individual proteins, dramatically decreased run time, and reproducible size and pI measurement for protein identification. The main innovation is a scheme that will couple capillary iso-electric focusing (CIEF) with multicapillary capillary-gel electrophoresis (CGE) to allow automated two-dimensional capillary-gel electrophoresis of protein samples to be performed. In Phase I, the coupling scheme will be developed and tested. In addition, the fluorescence detection chemistry using "on-column" detection on the capillary array will be developed. This will be a significant advance for the analysis of whole cell samples for clinical and research studies of cancerous and pre-cancerous tissue. PROPOSED COMMERCIAL APPLICATION: Many clinical and research labs involved in cancer research as well as proteomics research would benefit from the type of instrument that we are proposing to develop. Clinical labs for routine analysis would be our primary target, although a second design with more user control and flexibility for research applications would probably be the initial market.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    149800
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:149800\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SPECTRUMEDIX CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    STATE COLLEGE
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    16803
  • Organization District
    UNITED STATES